Research Overview
RESEARCH Title: Randomized Multi-Center Trial to Evaluate PEG-interferon alfa 2b plus ribavirin at two different doses for patients with chronic hepatitis C and relapse after combination therapy or nonresponse after monotherapy or combination therapy; Funded by: Integrated Therapeutics, Title: Comparison of PEG-interferon alfa 2b and two different doses of ribavirin for treatment of chronic hepatitis C in previously untreated adult subjects; Title: Long Term Follow-up Protocol to Assess Patients After Completing 24 Weeks of Follow-up in a SPRI Clinical Trial for the Treatment of Chronic Hepatitis C Sponsor: Schering Plough Research Institute; Title: Daily vs Thrice Weekly Interferon in Combination with Ribavirin for Patients with Chronic Hepatitis C who have not previously been treated;
